Skip to main content

Month: July 2022

Gilat Awarded Order of Over $7M from Tier-1 Mobile Network Carrier in APAC for 4G Cellular Backhaul Network Expansion

PETAH TIKVA, Israel, July 14, 2022 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions, and services, announced today it received an order in excess of $7 million from a Tier-1 mobile network carrier in the Asia Pacific (APAC) region for 4G cellular backhaul network expansion. Gilat’s SkyEdge II-c Capricorn VSATs will be used for cellular backhaul over satellite, further propelling the growth of the mobile carrier’s 4G/LTE network into rural zones lacking fiber access. “By enabling rapid and cost-effective network expansion, Gilat is helping this innovative mobile carrier to serve a growing base of customers and establish an enviable position in the industry,” said Michal Aharonov, Chief Commercial Officer at Gilat. “This follow-on order represents...

Continue reading

Form 8.3 – Serica Energy PLC

FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1.        KEY INFORMATION  (a)        Full name of discloser: Investec Wealth & Investment Limited(b)        Owner or controller of interests and short positions disclosed, if different from 1(a):         The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.N/A(c)        Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offereeSerica Energy Plc(d)        If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)        Date...

Continue reading

Form 8.3 – Kistos Plc

FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1.        KEY INFORMATION  (a)        Full name of discloser: Investec Wealth & Investment Limited(b)        Owner or controller of interests and short positions disclosed, if different from 1(a):         The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.N/A(c)        Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offereeKistos Plc(d)        If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)        Date...

Continue reading

Unity Bancorp Reports Quarterly Earnings of $9.5 Million

CLINTON, N.J., July 14, 2022 (GLOBE NEWSWIRE) — Unity Bancorp, Inc. (NASDAQ: UNTY), parent company of Unity Bank, reported net income of $9.5 million, or $0.88 per diluted share, for the quarter ended June 30, 2022, a 12.3% increase compared to net income of $8.4 million, or $0.80 per diluted share for the prior year’s second quarter. For the six months ended June 30, 2022, Unity reported net income of $18.6 million, or $1.74 per diluted share, a 9.7% increase compared to $16.9 million or $1.60 per diluted share for the prior year’s period. James A. Hughes, President and CEO, commented on the financial results: “Unity Bank is proud to report another outstanding quarter, where we generated $9.5 million of net income, or $0.88 per share, an increase of 12.3% over last year. This represents a 1.83% ROA, and 17.32% ROE. In addition,...

Continue reading

Johnson & Johnson, AbbVie, and Takeda Among Leading Companies in the Ulcerative Colitis Market | GlobalData Plc

Johnson & Johnson continues to be the market leader in the ulcerative colitis market LONDON, July 14, 2022 (GLOBE NEWSWIRE) — The “Ulcerative Colitis – Global Drug Forecast and Market Analysis to 2029” report offered by GlobalData covers the market forecast for the marketed and late-stage pipeline UC therapeutics. The model segments patients by severity, with mild-moderate, moderate-severe, and severe/fulminant segments. The total drug sales in the ulcerative colitis (UC) market was estimated to be $6.3 billion in 2019 across the 8MM and is expected to increase at a CAGR of more than 5% by 2029. During the forecast period, growth within the 8MM will largely be driven by the strong uptake of the IL-23 inhibitors (Skyrizi, mirikizumab, and Tremfya) and the new oral formulation S1P receptor modulators (Zeposia and etrasimod).To...

Continue reading

TRX Gold Delivers Production Growth and Lower Operating Costs

Reports Third Quarter ResultsPicture 1 Pictured: Dorè Bars from Buckreef Gold, Buckreef Gold 360 tpd Processing Plant at Night, Buckreef Gold Drill Rig in Northeast Extension, CIL Tank Construction at 1,000+ tpd Plant at Buckreef GoldTORONTO, July 14, 2022 (GLOBE NEWSWIRE) — TRX Gold Corporation (TSX:TNX) (NYSE American:TRX) (the “Company” or “TRX Gold”) today announced results for the third quarter of 2022 (“Q3 2022”). Financial results for Q3 2022 will be available on the Company’s website and will be filed on SEDAR and provided on EDGAR on or around July 14, 2022. Q3 2022 was another milestone for the Company as it reflected the first full quarter operating the 360 tpd processing plant at full design capacity and using the cash flow generated from mining operations to fund successful exploration. During Q3 2022 the Company...

Continue reading

FirstFarms A/S acquires shares in Agri Invest A/S

FirstFarms A/S has today acquired 1.67 % of the shares in Agri Invest A/S for at total price of 6,687,500 DKK. ”We see a potential in Agri Invest, which owns and operates 10,000 hectares of land in Romania. Our acquisition of shares in the company is a passive investment in line with our strategy about continuous acquisition, optimisation and sale of land,” says CEO of FirstFarms, Anders H. Nørgaard. The acquisition of shares does not affect the announced expectations for 2022 of and EBITDA in the level of 80-120 mDKK and an EBIT of 35-75 mDKK. Best regards,FirstFarms A/S For further information:Please visit our website www.firstfarms.com or contact CEO Anders H. Nørgaard on phone +45 75 86 87 87. About FirstFarms:FirstFarms is a Danish stock exchange listed company. We operate FirstFarms with responsibility for the surrounding communities,...

Continue reading

With 9.2% CAGR, Staffing Agency Software Market Worth USD 772.8 Million by 2029

According to Fortune Business Insights, the global Staffing Agency Software Market size is projected to reach USD 772.8 million in 2029, at a CAGR of 9.2% during the forecast period Pune, India, July 14, 2022 (GLOBE NEWSWIRE) — The global staffing agency software market size reached USD 390.9 million in 2021. The market value is estimated to rise from USD 418.3 million in 2022 to USD 772.8 million by 2029, exhibiting a CAGR of 9.2% during 2022-2029. The use of staffing agency software solutions across enterprises is increasing for sourcing, tracking, and recruiting candidates. The adoption of these solutions is higher across Small and Medium-sized Enterprises (SMEs). Rising technological advancements and digitalization in developing countries will drive the market growth during the projected timeframe, says Fortune Business Insights™,...

Continue reading

Form 8.3 – [CARETECH HOLDINGS PLC – 13 07 2022] – CGWL

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree CARETECH HOLDINGS PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position...

Continue reading

Share Buyback Transaction Details July 7 – July 13, 2022

Share Buyback Transaction Details July 7 – July 13, 2022 July 14, 2022 – Wolters Kluwer today reports that it has repurchased 112,200 of its own ordinary shares in the period from July 7, 2022, up to and including July 13, 2022, for €10.8 million and at an average share price of €96.60. These repurchases are part of the share buyback program announced on February 23, 2022, under which we intend to repurchase shares for up to €600 million during 2022. The cumulative amounts repurchased to date under this program are as follows: Share Buyback 2022Period Cumulative shares repurchased in period Total consideration(€ million) Average share price(€)2022 to date 3,516,264 323.7 92.06For the period starting May 5, 2022, up to and including August 1, 2022, we have engaged a third party to...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.